Our results suggest that BRCA1 overexpression inhibits the Warburg effect, decreases cancer cell growth and migration, and enhances sensitivity to anti-cancer treatments via downregulation of PKM2 regulated by PI3K/AKT signaling. The gene discussed is AKT1; the disease is cancer.